Nuveen’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Nuveen’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-107,352	Closed	-$1.25M	–	3591
2022 Q1	$1.25M	Buy	107,352 +54,447	+103%	+$648K	﹤0.01%	2721
2021 Q4	$672K	Sell	52,905 -6,079	-10%	-$77.1K	﹤0.01%	2986
2021 Q3	$773K	Sell	58,984 -1,867	-3%	-$27.2K	﹤0.01%	3074
2021 Q2	$1.05M	Buy	60,851 +11,247	+23%	+$214K	﹤0.01%	2989
2021 Q1	$907K	Buy	49,604 +5,528	+13%	+$116K	﹤0.01%	2916
2020 Q4	$829K	Buy	44,076 +8,864	+25%	+$191K	﹤0.01%	2874
2020 Q3	$743K	Buy	35,212 +10,640	+43%	+$249K	﹤0.01%	2808
2020 Q2	$709K	Buy	24,572 +11,332	+86%	+$341K	﹤0.01%	2765
2020 Q1	$463K	Buy	+13,240	New	+$428K	﹤0.01%	2803

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Nuveen's OYST Position: Q2 2022 in Review

Nuveen sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 107,352 shares — an estimated $1.25M sold.

Nuveen first reported a position in OYST in Q1 2020 and held it in 9 quarters. The position peaked at $1.25M in Q1 2022. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

Nuveen reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Nuveen sold 107,352 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $1.25M.
Nuveen first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
Nuveen's Oyster Point Pharma, Inc. Common Stock position peaked at $1.25M in Q1 2022.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.